NZ500183A - Method for treating pain and inflammation in dogs by administration of a COX-2 selective carprofen derivative - Google Patents

Method for treating pain and inflammation in dogs by administration of a COX-2 selective carprofen derivative

Info

Publication number
NZ500183A
NZ500183A NZ500183A NZ50018398A NZ500183A NZ 500183 A NZ500183 A NZ 500183A NZ 500183 A NZ500183 A NZ 500183A NZ 50018398 A NZ50018398 A NZ 50018398A NZ 500183 A NZ500183 A NZ 500183A
Authority
NZ
New Zealand
Prior art keywords
cox
carprofen
inhibition
activity
inflammatory
Prior art date
Application number
NZ500183A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to NZ516914A priority Critical patent/NZ516914A/en
Publication of NZ500183A publication Critical patent/NZ500183A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ500183A 1997-05-05 1998-05-01 Method for treating pain and inflammation in dogs by administration of a COX-2 selective carprofen derivative NZ500183A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ516914A NZ516914A (en) 1997-05-05 1998-05-01 Compositions containing COX-2 selective carprofen and derivatives thereof for treating pain and inflammation in dogs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
NZ500183A true NZ500183A (en) 2002-04-26

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ500183A NZ500183A (en) 1997-05-05 1998-05-01 Method for treating pain and inflammation in dogs by administration of a COX-2 selective carprofen derivative

Country Status (32)

Country Link
EP (1) EP0988034A1 (ko)
JP (1) JP2000513020A (ko)
KR (2) KR20010012300A (ko)
CN (1) CN1255059A (ko)
AP (1) AP9801234A0 (ko)
AR (2) AR011726A1 (ko)
AU (1) AU6932198A (ko)
BG (1) BG103852A (ko)
BR (1) BR9808720A (ko)
CA (1) CA2288759A1 (ko)
DZ (1) DZ2479A1 (ko)
EA (1) EA003696B1 (ko)
GT (1) GT199800063A (ko)
HR (1) HRP980244A2 (ko)
HU (1) HUP0001286A3 (ko)
ID (1) ID21311A (ko)
IL (1) IL132570A0 (ko)
IS (1) IS5220A (ko)
MA (1) MA26491A1 (ko)
NO (1) NO995389L (ko)
NZ (1) NZ500183A (ko)
OA (1) OA11213A (ko)
PA (1) PA8450601A1 (ko)
PE (1) PE72599A1 (ko)
PL (1) PL337003A1 (ko)
SK (1) SK148199A3 (ko)
TN (1) TNSN98059A1 (ko)
TW (1) TW590773B (ko)
UY (1) UY24989A1 (ko)
WO (1) WO1998050033A1 (ko)
YU (1) YU55899A (ko)
ZA (1) ZA983722B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
DE60023119T2 (de) * 1999-03-10 2006-07-20 G.D. Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001087343A2 (en) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
PL206268B1 (pl) 2000-06-13 2010-07-30 Wyethwyeth Kompozycja przeciwbólowa i/lub przeciwzapalna oraz jej zastosowanie
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
EP1307585B1 (en) 2000-08-07 2009-01-21 Vanderbilt University Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
MXPA06001288A (es) * 2003-07-31 2006-04-11 Upjohn Co Formulacion dispersable de un agente anti-inflamatorio.
EA200702280A1 (ru) * 2005-05-20 2008-04-28 Пфайзер Лимитед Синергические комбинации
JP2010523554A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド タクロリムスの医薬組成物
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
CN107582526A (zh) 2009-08-12 2018-01-16 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN105939713A (zh) 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 格拉匹纶组合物及其使用方法
AU2015341695B2 (en) 2014-11-07 2021-07-08 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2016112312A1 (en) * 2015-01-09 2016-07-14 Jaguar Animal Health Methods of treating diarrhea in companion animals
WO2021195346A1 (en) * 2020-03-25 2021-09-30 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
HUP0001286A2 (hu) 2000-11-28
GT199800063A (es) 1999-10-26
CA2288759A1 (en) 1998-11-12
WO1998050033A1 (en) 1998-11-12
PL337003A1 (en) 2000-07-31
EA199900895A1 (ru) 2000-06-26
ZA983722B (en) 1999-11-04
KR20010012300A (ko) 2001-02-15
DZ2479A1 (fr) 2003-02-01
AR011726A1 (es) 2000-08-30
AP9801234A0 (en) 1999-11-04
PE72599A1 (es) 1999-08-12
PA8450601A1 (es) 2000-05-24
MA26491A1 (fr) 2004-12-20
NO995389D0 (no) 1999-11-04
EA003696B1 (ru) 2003-08-28
OA11213A (en) 2003-07-14
SK148199A3 (en) 2001-09-11
IS5220A (is) 1999-10-19
AR039628A2 (es) 2005-03-02
YU55899A (sh) 2003-08-29
KR20040004406A (ko) 2004-01-13
UY24989A1 (es) 2001-10-25
AU6932198A (en) 1998-11-27
HUP0001286A3 (en) 2000-12-28
CN1255059A (zh) 2000-05-31
TW590773B (en) 2004-06-11
EP0988034A1 (en) 2000-03-29
NO995389L (no) 2000-01-04
ID21311A (id) 1999-05-20
HRP980244A2 (en) 1999-02-28
JP2000513020A (ja) 2000-10-03
BG103852A (en) 2000-06-30
BR9808720A (pt) 2000-07-11
IL132570A0 (en) 2001-03-19
TNSN98059A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
NZ500183A (en) Method for treating pain and inflammation in dogs by administration of a COX-2 selective carprofen derivative
US6399647B2 (en) Amide derivatives for antiangiogenic and/or antitumorigenic use
Shi et al. Clinical use and pharmacological properties of selective COX-2 inhibitors
CA2272463C (en) Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
Komers et al. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors
TW201002311A (en) Novel compositions and methods for treating hyperproliferative diseases
JP2002226401A (ja) うつ病の併用療法
US20180215710A1 (en) Methods for inhibiting native and promiscuous uptake of monoamine neurotransmitters
MXPA02009097A (es) Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa.
US20030212123A1 (en) COX-2 selective carprofen for treating pain and inflammation in dogs
BRPI0708059A2 (pt) formulação de niacina de baixo rubor
US20140163013A1 (en) Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
JP2003526663A (ja) Ｃｏｍｔ阻害剤の鎮痛剤としての用途
AU773615B2 (en) COX-2 selective carprofen for treating pain and inflammation in dogs
CN101563321B (zh) 4-(杂环基)烷基-n-(芳基磺酰基)吲哚化合物及其作为5-ht6配体的用途
NZ516914A (en) Compositions containing COX-2 selective carprofen and derivatives thereof for treating pain and inflammation in dogs
JP5579958B2 (ja) Ｃｏｘ−２インヒビターを含有する鎮痛及び抗炎症性組成物
Estato et al. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
CZ9903896A3 (cs) Léčivo, farmaceutický přípravek a souprava pro léčení nebo prevenci bolesti a zánětlivých procesů
JPWO2002066030A1 (ja) ジクロフェナクとオルノプロスチルからなる医薬組成物
JP2004511436A (ja) 失禁用医薬
MX2010006520A (es) Metodo y composicion para el tratamiento de una condicion mediada por alfa-adrenoceptor.
Kendall et al. Pharmacology of Analgesics
TW200908964A (en) Use of HDAC inhibitors for the treatment of gastrointestinal cancers
MXPA99008048A (en) Oxynolic developers oxidonitric releases for analgesic, anti-inflammatory use and as a sick modifier

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)